| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |